Benchmark lowered the firm’s price target on E.W. Scripps (SSP) to $8 from $10 and keeps a Buy rating on the shares. The firm says it gives Scripps “a lot of credit for creating a differentiated narrative,” but thinks large scale M&A is off the table until there is more clarity from Washington around the cap or an end to the current high-profile antitrust case. However, “that does not mean incremental progress cannot be made in the interim,” the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SSP:
